Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 17, 2017, Pages 4507-4512

  Graham, Carrie E ^a   Cruz, Melissa R ^a   Garsin, Danielle A ^a   Lorenz, Michael C ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Bacteriocins; Biofilms; Candida albicans; Enterococcus faecalis

Indexed keywords

ANTIFUNGAL AGENT; BACTERIOCIN;

ADULT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL INVASION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; EPITHELIUM CELL; FUNGAL DEVELOPMENT; FUNGAL VIRULENCE; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MOUSE; NEMATODIASIS; NONHUMAN; OROPHARYNX CANDIDIASIS; PRIORITY JOURNAL; YEAST CELL; ANIMAL; BAGG ALBINO MOUSE; CAENORHABDITIS ELEGANS; CANDIDIASIS; DRUG EFFECT; FUNGUS HYPHAE; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; OROPHARYNX; PATHOGENICITY; RAW 264.7 CELL LINE; VIRULENCE;

ANIMALS; BACTERIOCINS; BIOFILMS; CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; CANDIDIASIS; ENTEROCOCCUS FAECALIS; HYPHAE; MACROPHAGES; MICE; MICE, INBRED BALB C; OROPHARYNX; RAW 264.7 CELLS; VIRULENCE;

EID: 85018424186     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1620432114     Document Type: Article

References (63)

1. Agudelo Higuita NI, Huycke MM (2014) Enterococcal disease, epidemiology, and implications for treatment. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection, eds Gilmore MS, Clewell DB, Ike Y, Shankar N (Mass Eye Ear Infirmary, Boston).
2. Lebreton F, Willems RJL, Gilmore MS (2014) Enterococcus diversity, origins in nature, and gut colonization. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection, eds Gilmore MS, Clewell DB, Ike Y, Shankar N (Mass Eye Ear Infirmary, Boston).
3. Moran G, Coleman D, Sullivan D (2012) An introduction to the medically relevant Candida species. Candida and Candidiasis, eds Calderone RA, Clancy CJ (Am Soc Microbiol, Washington), pp 11-26.
4. Oever JT, Netea MG (2014) The bacteriome-mycobiome interaction and antifungal host defense. Eur J Immunol 44:3182-3191.
5. Mayr FB, Yende S, Angus DC (2014) Epidemiology of severe sepsis. Virulence 5:4-11.
6. Hermann C, Hermann J, Munzel U, Rüchel R (1999) Bacterial flora accompanying Candida yeasts in clinical specimens. Mycoses 42:619-627.
7. Dunny GM, Hancock LE, Shankar N (2014) Enterococcal biofilm structure and role in colonization and disease. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection, eds Gilmore MS, Clewell DB, Ike Y, Shankar N (Mass Eye Ear Infirmary, Boston).
8. Nobile CJ, Johnson AD (2015) Candida albicans biofilms and human disease. Annu Rev Microbiol 69:71-92.
9. Desai JV, Mitchell AP, Andes DR (2014) Fungal biofilms, drug resistance, and recurrent infection. Cold Spring Harb Perspect Med 4:a019729.
10. Garsin DA, Lorenz MC (2013) Candida albicans and Enterococcus faecalis in the gut: Synergy in commensalism? Gut Microbes 4:409-415.
11. Peleg AY, Hogan DA, Mylonakis E (2010) Medically important bacterial-fungal interactions. Nat Rev Microbiol 8:340-349.
12. Peters BM, Jabra-Rizk MA, O'May GA, Costerton JW, Shirtliff ME (2012) Polymicrobial interactions: Impact on pathogenesis and human disease. Clin Microbiol Rev 25: 193-213.
13. Hogan DA, Kolter R (2002) Pseudomonas-Candida interactions: An ecological role for virulence factors. Science 296:2229-2232.
14. Morales DK, et al. (2013) Control of Candida albicans metabolism and biofilm formation by Pseudomonas aeruginosa phenazines. MBio 4:e00526-12.
15. Peters BM, et al. (2010) Microbial interactions and differential protein expression in Staphylococcus aureus-Candida albicans dual-species biofilms. FEMS Immunol Med Microbiol 59:493-503.
16. Bamford CV, et al. (2009) Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect Immun 77:3696-3704.
17. Cruz MR, Graham CE, Gagliano BC, Lorenz MC, Garsin DA (2013) Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans. Infect Immun 81: 189-200.
18. Rautemaa R, Ramage G (2011) Oral candidosis-clinical challenges of a biofilm disease. Crit Rev Microbiol 37:328-336.
19. Wong L, Sissons C (2001) A comparison of human dental plaque microcosm biofilms grown in an undefined medium and a chemically defined artificial saliva. Arch Oral Biol 46:477-486.
20. Van den Driessche F, Rigole P, Brackman G, Coenye T (2014) Optimization of resazurin-based viability staining for quantification of microbial biofilms. J Microbiol Methods 98:31-34.
21. Staab JF, Bahn YS, Sundstrom P (2003) Integrative, multifunctional plasmids for hypha-specific or constitutive expression of green fluorescent protein in Candida albicans. Microbiology 149:2977-2986.
22. Baillie GS, Douglas LJ (1999) Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol 48:671-679.
23. Ramage G, Van de Walle K, López-Ribot JL, Wickes BL (2002) The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol Lett 214:95-100.
24. Bourgogne A, Hilsenbeck SG, Dunny GM, Murray BE (2006) Comparison of OG1RF and an isogenic fsrB deletion mutant by transcriptional analysis: The Fsr system of Enterococcus faecalis is more than the activator of gelatinase and serine protease. J Bacteriol 188:2875-2884.
25. Dundar H, et al. (2015) The fsr quorum-sensing system and cognate gelatinase orchestrate the expression and processing of Proprotein EF-1097 into the mature antimicrobial peptide enterocin O16. J Bacteriol 197:2112-2121.
26. Teixeira N, et al. (2013) Drosophila host model reveals new enterococcus faecalis quorum-sensing associated virulence factors. PLoS One 8:e64740.
27. Swe PM, et al. (2007) ef1097 and ypkK encode enterococcin V583 and corynicin JK, members of a new family of antimicrobial proteins (bacteriocins) with modular structure from Gram-positive bacteria. Microbiology 153:3218-3227.
28. Breger J, et al. (2007) Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog 3:e18.
29. Lo HJ, et al. (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949.
30. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL (2003) Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2:1053-1060.
31. Lorenz MC, Bender JA, Fink GR (2004) Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot Cell 3:1076-1087.
32. Vylkova S, Lorenz MC (2014) Modulation of phagosomal pH by Candida albicans promotes hyphal morphogenesis and requires Stp2p, a regulator of amino acid transport. PLoS Pathog 10:e1003995.
33. Sangeorzan JA, et al. (1994) Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 97:339-346.
34. Rhodus NL, Bloomquist C, Liljemark W, Bereuter J (1997) Prevalence, density, and manifestations of oral Candida albicans in patients with Sjögren's syndrome. J Otolaryngol 26:300-305.
35. Willis AM, et al. (1999) Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet Med 16:675-679.
36. Solis NV, Filler SG (2012) Mouse model of oropharyngeal candidiasis. Nat Protoc 7: 637-642.
37. Moyes DL, et al. (2016) Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature 532:64-68.
38. Khot PD, Ko DL, Fredricks DN (2009) Sequencing and analysis of fungal rRNA operons for development of broad-range fungal PCR assays. Appl Environ Microbiol 75: 1559-1565.
39. Rickerts V, Khot PD, Ko DL, Fredricks DN (2012) Enhanced fungal DNA-extraction from formalin-fixed, paraffin-embedded tissue specimens by application of thermal energy. Med Mycol 50:667-672.
40. Pierce CG, et al. (2015) A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance. NPJ Biofilms Microbiomes 1:15012.
41. Mason KL, et al. (2012) Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis. Infect Immun 80: 150-158.
42. Mason KL, et al. (2012) Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy. Infect Immun 80:3371-3380.
43. Hogan DA, Vik A, Kolter R (2004) A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol 54:1212-1223.
44. Azoulay E, et al.; Outcomerea Study Group (2006) Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest 129:110-117.
45. Neely AN, Law EJ, Holder IA (1986) Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes. Infect Immun 52:200-204.
46. Kristich CJ, Chandler JR, Dunny GM (2007) Development of a host-genotypeindependent counterselectable marker and a high-frequency conjugative delivery system and their use in genetic analysis of Enterococcus faecalis. Plasmid 57:131-144.
47. Montealegre MC, La Rosa SL, Roh JH, Harvey BR, Murray BE (2015) The Enterococcus faecalis EbpA pilus protein: Attenuation of expression, biofilm formation, and adherence to fibrinogen start with the rare initiation codon ATT. MBio 6:e00467-15.
48. Fox KA, et al. (2009) Multiple posttranscriptional regulatory mechanisms partner to control ethanolamine utilization in Enterococcus faecalis. Proc Natl Acad Sci USA 106: 4435-4440.
49. Brothers KM, Newman ZR, Wheeler RT (2011) Live imaging of disseminated candidiasis in zebrafish reveals role of phagocyte oxidase in limiting filamentous growth. Eukaryot Cell 10:932-944.
50. Nobile CJ, et al. (2012) A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148:126-138.
51. Nobile CJ, Mitchell AP (2005) Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol 15:1150-1155.
52. Hope IA (1999) C. elegans A Practical Approach (Oxford Univ Press, Oxford).
53. Miramón P, Lorenz MC (2016) The SPS amino acid sensor mediates nutrient acquisition and immune evasion in Candida albicans. Cell Microbiol 18:1611-1624.
54. Rocha CR, et al. (2001) Signaling through adenylyl cyclase is essential for hyphal growth and virulence in the pathogenic fungus Candida albicans. Mol Biol Cell 12: 3631-3643.
55. Del Papa MF, Perego M (2008) Ethanolamine activates a sensor histidine kinase regulating its utilization in Enterococcus faecalis. J Bacteriol 190:7147-7156.
56. Sherman F (1991) Getting started with yeast. Methods Enzymol 194:3-21.
57. Moy TI, et al. (2006) Identification of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci USA 103:10414-10419.
58. Miramón P, et al. (2014) A family of glutathione peroxidases contributes to oxidative stress resistance in Candida albicans. Med Mycol 52:223-239.
59. Fonzi WA, Irwin MY (1993) Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.
60. Butler G, et al. (2009) Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 459:657-662.
61. Murray BE, et al. (1993) Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function. J Bacteriol 175:5216-5223.
62. Qin X, Singh KV, Weinstock GM, Murray BE (2001) Characterization of fsr, a regulator controlling expression of gelatinase and serine protease in Enterococcus faecalis OG1RF. J Bacteriol 183:3372-3382.
63. Leenhouts K, et al. (1996) A general system for generating unlabelled gene replacements in bacterial chromosomes. Mol Gen Genet 253:217-224.